IMUC has been and will continue to be a conservator of shareholders $..this is something that is known.
I hope this month we start to breakout. If not we should see good things from the PR company right after the 1st of the year..moving forward in 2014 is going to be fun. GLTA
Cytomedix just had two significant doors kicked-open for them by CMS and the new payment rules to take effect January 1, 2014. Not only are there now pathways for reimbursement under both PFS and HOPPS, but AutoloGel might have one of the best economics in the industry under the new rules.
Sentiment: Strong Buy
Sue..what does this mean?
This payment level is consistent with the proposed rule announced by CMS in July this year.
KOKO..I expect a double barrel PR tomorrow..If Jason N was on the phone with Marety Friday then he has one heading to the SA wire and of course CMXI will have an annoucement. Given the apparent strong hand I don't miss a meaningless "Oh yes were are pleased"..but something more informative..I was able yo grab share under .50 Friday (not by much)..I really have a short fuse about the managemnt bashers on this board..did they make a judgement error in regards to CMS ..yep. Do they have skin in the game..yep..thats why I'm still here. The reverse split if one occurs will be well thought out to attain, maintain uplisting and garner institutional buying..thats the goal..and a damn good one...MHO..GLTA.
Oh yeah..they don't care one bit about the 40% owned by insiders..your a basher..get a life..
Jason Napodano, 29 Nov
Just spent 40 min on the phone with $CMXI CEO. He's happy with the decision. Expects 70% all-in margin on AutoloGel going forward.
Reimbursement for AutoloGel in 2013 under HOPPS (free-standing wound care clinics) was $74. It will be $411 in 2014. That's huge for $CMXI
$CMXI now has a path to sell AutoloGel and make 70% gross margin, with full national coverage under PFS and HOPPS network.
AutoloGel has been RE-classified as a Level-2 Skin Substitute under APC-0327, and will be reimbursed at $411. Up from previous $83! $CMXI
Again the insiders own 40% of the shares..If we get a good bounce on PPS..say $1.00...there would be no reason to do the R/S if they could sell it lock stock and barrel. So one of the big players in wound care get a bloody nose from new regulations..sure would be an easy way to save that revenue..so what would CMXI say to an offer of $800,000,000..$500,000,000..5x, 8x, 10x? Anybody got a thought on this? Sure would be easy for one of the big guys to max this out in short order..GLTA
I would assume they have 75% margin. If so cost is around $250.00 (long time ago I remember seeing a retail cost scenario of $950.00 too $1150.00) plus disposables which are high margin. Looks to me its better than kissing your sister.I think the 5-10% market penetration sounds low..so say 20% margin on 30M sales...6M to top line in short order would be nice..
I guess your right..the statement from CMS on the delay said on or before 11-27..the company just repeated what they said. I try to be patient but this has been ridiculously protracted by CMS..over a year..thanks..